Insight on Manufacturing

March 2021

Issue link: http://www.insightdigital.biz/i/1349182

Contents of this Issue

Navigation

Page 28 of 31

w w w.in s i g h t o n m f g . c o m March 2021 • /INSIGHT ON MANUFACTURING | 29 Designed by Boulder Associates Inc. and built by Boldt, the prefabricated, modular units are designed to be deployed in any location, provide safe and efficient vaccination settings for health care workers and individuals, and serve as a long-term space solution post-pandemic. Developed in collaboration with public health experts, VaxMod can deliver 39 percent more vaccines per hour with 7 percent lower staffing levels, compared to model vaccination clinics identified by the Centers for Disease Control and Prevention. VaxMod is designed for rapid deployment and to administer vaccinations to walk-in patients or individuals in their vehicles. The system can be scaled to meet the volume needed in specific communities. The operation is estimated to vaccinate more than 1,100 patients per eight-hour shift and can be staffed using 27 full- time employees. Modules can function as freestanding units or be connected to one another with segregated spaces for health care workers and patients. In a post-pandemic setting, the VaxMod can be repurposed for a variety of uses. Space can be modified and used for rapid testing and screening for patient populations or annual f lu clinics. Modules could also be used for health screening and maintenance clinics to fill a critical need in the care of chronic diabetic or cardiovascular patients. BEMIS MANUFACTURING INVESTS IN CARDIOVASCULAR MONITORING DEVICE Bemis Manufacturing Co. increased its investment in a New York startup that developed an in-home cardiovascular monitoring device. Casana, previously known as Heart Health Intelligence Inc., recently closed on a $14 million funding round that included follow-on capital from Bemis. In 2020, Bemis led a $2.2 million seed round in the company, which developed The Heart Seat, an internet-connected toilet seat that captures cardiac data from a patient's home. Casana previously stated Bemis will produce The Heart Seat. Casana will use the financing to bring The Heart Seat to market. Casana plans to pursue FDA clearance to further validate the clinical-grade technology built into The Heart Seat, which makes it a unique Internet of Things device for heart disease management. The Heart Seat is a cloud-connected, self-contained toilet seat-based cardiovascular monitoring system that measures the health parameters for assessing heart health. It already has been tested through multiple peer- reviewed research studies and is pursuing Food and Drug Administration clearance. By using the passive and consistent home cardiac monitoring data from The Heart Seat, doctors can gain a better understanding of chronic conditions and a greater ability to address patients' needs as they arise. Founded in 1984, Sure Controls provides manufacturing companies with automation products and services in thermal & fluid processes, web handling, robotics, and plant intelligence. Our mission is delighting our customers with design foresight, product leadership and unequaled responsiveness. N981 Tower View Drive Greenville, WI 54942 800.844.8405 salesinfo@surecontrols.com www.surecontrols.com Plant Automation to Make You Smile

Articles in this issue

Links on this page

view archives of Insight on Manufacturing - March 2021